Download presentation
Presentation is loading. Please wait.
Published byWinifred Rogers Modified over 6 years ago
1
Frequency of Pap testing in women aged 15-29 years in Alberta: A case of over-screening?
Sayeeda Amber Sayed MBBS MPH Christopher Naugler MD FRCPS James A Dickinson MBBS PhD Thanks to Maggie Guo MSc Depts of Family Medicine Community Health Sciences Laboratory Medicine
2
Canadian Policy Began with annual smears
Walton report 1976: every 3 years Stop after hysterectomy, or age 60 Canadian Task Force on Preventive Health Care (CTFPHC): 1991 Every 3 years from sexual debut 18 to 69 Sabotaged immediately
3
If a little is good, more must be better?
4
Sunnybrook and Women’s Health Sciences Centre http://www
All women should have regular Pap smears starting at the age of 18 or when they become sexually active. Many physicians believe that even virginal women should begin regular Pap tests at the age of 18. Women who have had a hysterectomy (surgical removal of the uterus) and those past menopause still need to have regular Pap tests. Women who have had four normal Pap tests in the previous ten years may discontinue Pap tests at the age of 70. Accessed July 2004
5
Sunnybrook and Women’s Health Sciences Centre http://www
All women should have regular Pap smears starting at the age of 18 or when they become sexually active. Many physicians believe that even virginal women should begin regular Pap tests at the age of 18. Women who have had a hysterectomy (surgical removal of the uterus) and those past menopause still need to have regular Pap tests. Women who have had four normal Pap tests in the previous ten years may discontinue Pap tests at the age of 70. Medical rape Accessed July 2004
6
Sunnybrook and Women’s Health Sciences Centre http://www
All women should have regular Pap smears starting at the age of 18 or when they become sexually active. Many physicians believe that even virginal women should begin regular Pap tests at the age of 18. Women who have had a hysterectomy (surgical removal of the uterus) and those past menopause still need to have regular Pap tests. Women who have had four normal Pap tests in the previous ten years may discontinue Pap tests at the age of 70. Uncomfortable and cruel Because there is so little disease, then of course, pap testing is doing it! Accessed July 2004
7
Effect on Mortality and Incidence
Good national data Mortality: death register National available from 1932 Incidence: Cancer registries National available from 1972
8
Age-Specific Incidence of Invasive Cervical Cancer in Canada, 1972-2006
40 35 30 25 Rate per 100,000 20 When data is arranged by years. Greatest effects in middle age. Incidence rates dropped to 1/3 for most women over 40. Lower absolute reductions and prevented fractions at younger ages 15 10 5 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 Age of group (years) Dickinson JA, Stankiewicz A, Popadiuk C, Pogany L, Onysko J Miller AB. BMC Public Health :992 8 8
9
Mortality from Invasive Cervical Cancer in Canada in Periods from 1972 to 2006
30 28 26 24 22 20 18 16 Rate per 100,000 14 12 For mortality: the reduction is steadily greater with older age, both proportional and absolute. Problems at young and old end. Young: minimal effect. Old: still rising mortality: why? 10 8 6 4 2 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 Age group Dickinson JA, Stankiewicz A, Popadiuk C, Pogany L, Onysko J Miller AB. BMC Public Health :992 9 9
10
Guideline changes in Alberta
Pre 2009; start age 18, annual screening 2009 start age 21, 3 tests in 5 yrs then 3 yr 2013 CTFPHC based on epidemiology Start age 25, every 3 years 2016 Alberta Guidelines Follow CTFPHC
11
How did screening change in response to guidelines?
Calgary Lab Services Services for city of Calgary: ~ 1 Mill Unified database Measure: Pap tests Major biopsies
12
Pap tests by age in Calgary 2006-2015
Alberta Guideline CTFPHC
13
Changes Major reduction around 2009:
Alberta guidelines No effect of 2013 Canadian Task Force Rates dropping rapidly for Teenagers But still too many Rates still over 33% for >22 yrs Implies many more often than 3 yearly
14
Rate of abnormal tests in the population
15
Effect on abnormal test rate?
Later start, longer intervals, fewer tests Time to develop more severe abnormalities Disease should be concentrated Hypotheses Higher abnormal rate among those tested Higher biopsy rate among those tested
16
Rates of abnormal tests in women who had a test 2007-2015
Abnormal rates peak for yr old. Much lower for 25yrs. Largely remains flat, despite reductions Only effect for teenagers in last few years. Perhaps effect of CTFPHC 2013
17
Rates of abnormal tests in women who had a test 2007-2015
Abnormal rates peak for yr old. Much lower for 25yrs. Largely remains flat, despite reductions Only effect for teenagers in last few years. Perhaps effect of CTFPHC 2013
18
Biopsy rates among tested women
Note his set is only for the years after 2009. Biopsy rates low for teenagers, peak 22/23, lower thereafter.
19
Outcomes Abnormal test rates steady
Except: Reducing in cohort with HPV vaccine No concentration of disease Peak in young 20s, lower with age Biopsy rates dropping: before HPV reductions ? Change in disease ? Changes in diagnosis by pathologists ? Changes in practice: referrals, colposcopy
20
Conclusions Less testing does not concentrate disease
Suggests that rates of abnormalities in unimmunized cohorts are similar, regardless of testing rates. Vast majority are false positives Pap testing young women causes (random?) harm for 10-20%, for unmeasurably small benefit.
22
Gift Certificate Courtesy of: Your Family Physician
PAP Test Happy 21st Birthday You are now ready for your first Pap Test! Make an appointment with us Today
23
How do we change Physicians? Patients?
James A. Dickinson, Gina Ogilvie, Dirk Van Niekerk, and Cathy Popadiuk. Evidence that supports policies to delay cervical screening until after age 25 years CMAJ March 13, :E380-E381; doi: /cmaj
24
Frequency of Pap testing in women aged 15-29 years in Alberta: Clearly a case of over-screening.
Sayeeda Amber Sayed MBBS MPH Christopher Naugler MD FRCPS James A Dickinson MBBS PhD Thanks to Maggie Guo MSc Depts of Family Medicine Community Health Sciences Laboratory Medicine
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.